Department of Biochemical Engineering, University College London, Bernard Katz Building, Gower Street, London, WC1E 6BT, United Kingdom.
Cytiva Europe Limited, 5 Harbourgate Business Park, Southampton Road, Portsmouth, Hampshire PO6 4BQ, United Kingdom.
ACS Synth Biol. 2024 Sep 20;13(9):2710-2717. doi: 10.1021/acssynbio.4c00403. Epub 2024 Aug 23.
Recombinant adeno-associated viruses (rAAVs) have emerged as important tools for gene therapy and, more recently, vaccine development. Nonetheless, manufacturing can be costly and time-consuming, emphasizing the importance of alternative production platforms. We investigate the potential of -based cell-free protein synthesis (CFPS) to produce recombinant AAV5 virus-like particles (VLPs). AAV5 virus protein 3 (VP3) constructs, both with and without Strep-tag II, were expressed with CFPS. Lower reaction temperatures resulted in increased solubility, with the untagged variant containing nearly 90% more soluble VLP VP3 protein at 18 °C than at 37 °C. Affinity chromatography of N-terminally Strep(II)-tagged VP3 enabled successful isolation with minimal processing. DLS and TEM confirmed the presence of ∼20 nm particles. Furthermore, the N-terminally tagged AAV5 VP3 VLPs were biologically active, successfully internalizing into HeLa cells. This study describes an innovative approach to AAV VLP production using -based CFPS, demonstrating its potential for rapid and biologically active AAV VLP synthesis.
重组腺相关病毒(rAAV)已成为基因治疗的重要工具,最近也成为疫苗开发的重要工具。然而,制造过程可能既昂贵又耗时,这强调了替代生产平台的重要性。我们研究了基于细胞的无细胞蛋白质合成(CFPS)生产重组 AAV5 病毒样颗粒(VLPs)的潜力。使用 CFPS 表达了带有和不带有 Strep-tag II 的 AAV5 病毒蛋白 3(VP3)构建体。较低的反应温度可提高溶解度,在 18°C 时,未标记的变体中约有 90%的可溶性 VLP VP3 蛋白,而在 37°C 时则为 90%。N 端 Strep(II)-标记的 VP3 的亲和层析可实现最小处理的成功分离。DLS 和 TEM 证实存在约 20nm 的颗粒。此外,N 端标记的 AAV5 VP3 VLPs 具有生物活性,可成功进入 HeLa 细胞。本研究描述了一种使用基于细胞的 CFPS 生产 AAV VLP 的创新方法,证明了其快速且具有生物活性的 AAV VLP 合成的潜力。